These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2688045)

  • 1. [Platelet antiaggregants in other pathologies].
    Jouve R
    Rev Prat; 1989 Nov; 39(25):2241-3. PubMed ID: 2688045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
    Violi F; Balsano F
    Clin Trials Metaanal; 1994 Apr; 29(1):81-7. PubMed ID: 10150187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
    Konstantopoulos K; Mousa SA
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet drugs.
    De Meyer SF; Vanhoorelbeke K; Broos K; Salles II; Deckmyn H
    Br J Haematol; 2008 Aug; 142(4):515-28. PubMed ID: 18513285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet drugs in cardiovascular diseases.
    Weston C; Rao U
    Int J Clin Pract; 2003 Dec; 57(10):898-905. PubMed ID: 14712893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approach to diabetic retinopathy.
    De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
    Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet antiaggregants].
    Verstraeten L; François P
    J Pharm Belg; 1991; 46(4):261-5. PubMed ID: 1795215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adequacy of prescribing the disaggregants in vascular pathology of the eye fundus and in primary open-angle glaucoma].
    Mukha AI
    Vestn Oftalmol; 2005; 121(1):30-3. PubMed ID: 15759845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation].
    Decoene C; Vincentelli A; Fabre O; Crepin F; Pol A
    Ann Fr Anesth Reanim; 2005 Oct; 24(10):1275-7. PubMed ID: 16125359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
    Cavendish JJ; Safani M
    Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Longterm treatment of POAD with anticoagulants and platelet inhibitors after endovascular procedures and vascular surgery: what is evidence based?].
    Landgraf H
    Hamostaseologie; 2006 Aug; 26(3):239-44; quiz 245-6. PubMed ID: 16906242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncardiac applications of glycoprotein IIb/IIIa inhibitors.
    Almeda FQ; Schaer GL
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):530-8. PubMed ID: 15274167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy for vascular interventions.
    Comerota AJ; Thakur S
    Perspect Vasc Surg Endovasc Ther; 2008 Mar; 20(1):28-35. PubMed ID: 18388025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization procedures.
    Dangas G; Fuster V
    Rev Port Cardiol; 1999 Feb; 18 Suppl 1():I49-53. PubMed ID: 10191675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiplatelet agents and their therapeutic use].
    Lecompte T
    Rev Prat; 1999 Oct; 49(15):1627-33. PubMed ID: 10581992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet antiaggregants and atheromatous arteriopathy of the lower limbs].
    Lévesque H; Cailleux N; Courtois H
    Rev Med Interne; 1996; 17(2):163-8. PubMed ID: 8787090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet therapy in children.
    Israels SJ; Michelson AD
    Thromb Res; 2006; 118(1):75-83. PubMed ID: 16709476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.